Prophylactic application of an anti-cytomegalovirus hyperimmunoglobulin in allogeneic bone marrow transplant recipients.
D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications / Q000628:therapy; D016026:Bone Marrow Transplantation; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D007938:Leukemia / Q000150:complications / Q000628:therapy*; D008297:Male; D011446:Prospective Studies
D007106:Immune Sera; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin